Physician profile
Albert P Hamner
NPI 1801803390
$3,475.68
in general payments reported to CMS, 2019-2025
20 companies · $806 in 2025
The $806 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $239 · 2021: $250 · 2022: $376 · 2023: $509 · 2024: $516 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528 · Education: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.24 |
| Education | $302.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,105.24 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $458.15 | 2019-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $324.38 | 2021-2024 | Dupixent |
| Genzyme Corporation | $193.30 | 2019-2025 | |
| Mylan Specialty L.P. | $177.36 | 2019-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $171.48 | 2019-2023 | |
| Harmony Biosciences LLC | $163.94 | 2020-2025 | |
| Verona Pharma, INC. | $146.26 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $135.75 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $118.98 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.68 | 2019-2023 | Spiriva Respimat |
| Amgen INC. | $70.24 | 2021-2024 | Tezspire |
| Sunovion Pharmaceuticals INC. | $65.40 | 2019-2020 | |
| Lilly USA, LLC | $44.38 | 2025 | Zepbound |
| Viatris Specialty LLC | $43.08 | 2025 | Yupelri |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $40.38 | 2019 | |
| Inspire Medical Systems, INC. | $35.07 | 2024 | Inspire |
| Apria Healthcare LLC | $29.58 | 2021 | |
| Axsome Therapeutics, INC. | $29.09 | 2025 | Sunosi |
| United Therapeutics Corporation | $18.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Hamner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.